The above in vitro experiment results were in line with the in vivo results and they together confirmed that CEA‐CAR‐T cell in combination with rhIL‐12 had even better anti‐tumor effect than CEA‐CAR‐T cell treatment. Here, CEACAM5 is linked to neoplasm.